T2 Biosystms Inc (TTOO)

Currency in USD
0.0152
-0.0148(-49.33%)
Closed·
TTOO Scorecard
Full Analysis
Operates with a significant debt burden
TTOO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.01500.0152
52 wk Range
0.00025.2900
Key Statistics
Prev. Close
0.03
Open
0.0151
Day's Range
0.015-0.0152
52 wk Range
0.0002-5.29
Volume
10.85K
Average Volume (3m)
88.06K
1-Year Change
-99.7%
Book Value / Share
-0.67
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TTOO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

T2 Biosystms Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

T2 Biosystms Inc Company Profile

T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, an instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Compare TTOO to Peers and Sector

Metrics to compare
TTOO
Peers
Sector
Relationship
P/E Ratio
0.0x−2.8x−0.5x
PEG Ratio
0.00−0.090.00
Price/Book
0.0x1.4x2.6x
Price / LTM Sales
0.1x4.4x3.2x
Upside (Analyst Target)
-278.9%41.4%
Fair Value Upside
Unlock32.2%6.0%Unlock

Earnings

Latest Release
Nov 14, 2024
EPS / Forecast
-0.57 / -2.10
Revenue / Forecast
1.99M / 2.90M
EPS Revisions
Last 90 days

TTOO Income Statement

People Also Watch

2.4400
KNW
-14.69%
0.980
WINT
-3.92%
2.480
RSLS
-9.16%
12.120
NUWE
-6.77%
21.990
SBET
-5.70%

FAQ

What Stock Exchange Does T2 Biosystms Inc Trade On?

T2 Biosystms Inc is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for T2 Biosystms Inc?

The stock symbol for T2 Biosystms Inc is "TTOO."

What Is the T2 Biosystms Inc Market Cap?

As of today, T2 Biosystms Inc market cap is 426.29K.

What Is T2 Biosystms Inc's Earnings Per Share (TTM)?

The T2 Biosystms Inc EPS (TTM) is -4.08.

From a Technical Analysis Perspective, Is TTOO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has T2 Biosystms Inc Stock Split?

T2 Biosystms Inc has split 2 times.

How Many Employees Does T2 Biosystms Inc Have?

T2 Biosystms Inc has 113 employees.

What is the current trading status of T2 Biosystms Inc (TTOO)?

As of 27 Jul 2025, T2 Biosystms Inc (TTOO) is trading at a price of 0.02, with a previous close of 0.03. The stock has fluctuated within a day range of 0.02 to 0.02, while its 52-week range spans from 0.00 to 5.29.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.